Sep 19, 2026 10:00AM
Sep 15, 2026 09:01AM
Sep 15, 2026 09:00AM
Aug 26, 2026 03:09AM
Aug 25, 2026 10:00AM
Aug 25, 2026 10:00AM
Aug 10, 2026 07:30AM Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
Aug 10, 2026 07:30AM
Aug 3, 2026 04:05PM
Jun 16, 2026 04:06PM
Jun 16, 2026 04:05PM
Jun 12, 2026 08:01AM
Jun 12, 2026 08:00AM
Jun 4, 2026 07:45AM Jazz Pharmaceuticals to present 21 abstracts at SLEEP 2026 conference
Jun 4, 2026 07:45AM
May 27, 2026 05:00PM
May 27, 2026 05:00PM
May 5, 2026 04:05PM
Apr 27, 2026 07:45AM
Apr 27, 2026 07:45AM
Apr 21, 2026 04:05PM Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)
Apr 9, 2026 07:45AM
Mar 24, 2026 01:49PM
Mar 18, 2026 07:44AM
Feb 24, 2026 04:05PM
Jan 12, 2026 07:06AM
Jan 12, 2026 07:05AM
Jan 6, 2026 01:33PM Jazz Pharmaceuticals reports positive Ziihera cancer trial results
Jan 6, 2026 01:32PM
Dec 5, 2025 09:01AM
Dec 5, 2025 09:00AM
Dec 2, 2025 04:05PM
Dec 2, 2025 04:05PM
Nov 18, 2025 04:59AM
Nov 17, 2025 06:00AM JAZZ reports positive phase 3 results for Ziihera in gastric cancer
Nov 17, 2025 06:00AM
Nov 11, 2025 07:45AM
Nov 11, 2025 07:45AM
Nov 5, 2025 04:05PM
Oct 3, 2025 08:05AM
Oct 2, 2025 06:38PM
Oct 2, 2025 06:37PM FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Oct 2, 2025 03:33PM
Sep 22, 2025 07:45AM
Sep 22, 2025 07:45AM
Sep 11, 2025 08:18AM
Sep 9, 2025 07:45AM
Sep 9, 2025 07:45AM
Aug 20, 2025 04:15PM Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025
Aug 6, 2025 03:08PM

331,995 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All